Ilmar C Kruis (Ilmar Kruis)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Neuropathic Pain

Spinal Cord Injury

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Ilmar C Kruis, Mariëtte H Driessens
Pain while injecting emicizumab predominant in children, a report of Dutch patient experiences. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Ilmar C Kruis, Mariëtte H Driessens
Pain while injecting emicizumab predominant in children, a report of Dutch patient experiences. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Ilmar C Kruis, Mariëtte H Driessens
Pain while injecting emicizumab predominant in children, a report of Dutch patient experiences. Haemophilia : the official journal of the World Federation of Hemophilia 29 (2) (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Ilmar C Kruis, Mariëtte H Driessens
Pain while injecting emicizumab predominant in children, a report of Dutch patient experiences. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Anouk A M T Donners, Konrad van der Zwet, Antoine C G Egberts, Karin Fijnvandraat, Ron Mathôt, Ilmar C Kruis, Marjon H Cnossen, Roger Schutgens, Rolf T Urbanus, Kathelijn Fischer
DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A. BMJ open 13 (6) (2023)
Dominique P M S M Maas, Joline L Saes, Nicole M A Blijlevens, Marjon H Cnossen, Paul L den Exter, Ilmar C Kruis, Karina Meijer, Laurens Nieuwenhuizen, Marjolein Peters, Roger E G Schutgens, Waander L van Heerde, Saskia E M Schols, null null
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study. Journal of thrombosis and haemostasis : JTH 20 (4) (2022)